Navigation Links
Isis Pharmaceuticals to receive $1.4 million from Alnylam
Date:8/28/2012

in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO™, following regulatory approval.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENT
This press release includes forward-looking statements regarding Isis Pharmaceuticals' business, its intellectual property estate, and the therapeutic and commercial potential of the Company's products and technologies.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the planned commercialization of KYNAMRO, is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' an
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Aragon Pharmaceuticals Announces Appointment of Faheem Hasnain as Independent Director
2. ADVENTRX Pharmaceuticals To Present At The Rodman & Renshaw Annual Global Investment Conference On September 10
3. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
4. Savient Pharmaceuticals to Present at the Rodman & Renshaw 14th Annual Healthcare Conference
5. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
6. Vanda Pharmaceuticals to Participate in Two September Healthcare Investor Conferences
7. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
8. Actinium Pharmaceuticals Strengthens Management Team
9. Alexza Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference
10. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
11. Access Pharmaceuticals To Host Second Quarter Investor Call on Thursday, August 23, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 DST Health Solutions, LLC ... to health plans, integrated delivery systems, and health care ... Drug Management Service (MDMS) has jumped significantly. ... automate the pricing of medical prescription drug claims, MDMS ... automating their medical drug claims processes. As specialty drug ...
(Date:6/19/2013)... June 19, 2013   Life Technologies Corporation ... licensing agreement granting Suzhou Ribo Life Sciences (Ribo) ... therapeutics in China using ... proprietary siRNA molecules in combination with Invivofectamine® Rx ... human diseases with high unmet medical need in ...
(Date:6/19/2013)... June 19, 2013  It may seem like an odd ... breast cancer. But these were two of the most talked ... Annual Meeting & Expo that just convened in ... this focus by some of the top internal medicine experts ... with new research that can not only save lives, but ...
Breaking Medicine Technology:Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4
...  CIVCO Medical Solutions is introducing RAD-GUIDE, a needle ... 2011. RAD-GUIDE allows physicians a method for introducing ... adjusting planned punctures prior to needle entry. "As ... our expertise in ultrasound needle guidance to other ...
...   ZONARE Medical Systems, Inc., a developer of premium ... on abdominal ultrasound imaging solutions for diverse patient ... of the Radiology Society of North America, November ... ultrasound system delivers high-end image quality powered by ...
Cached Medicine Technology:CIVCO Enters CT Needle Guidance Market with RAD-GUIDE™ Launch 2ZONARE Medical Systems to Showcase z.one Ultrasound Platform at RSNA 2ZONARE Medical Systems to Showcase z.one Ultrasound Platform at RSNA 3
(Date:6/19/2013)... 19, 2013 Kleritec, Inc. announced the ... at http://www.kleritec.com . In the recent expansion ... and activities packages for pre-school and day care providers. ... method to aid teachers across the United States the ... learning. , Included in the art and activities packages ...
(Date:6/19/2013)... June 19, 2013 Today, Zane Benefits, ... Insurance Exchange . Zane Benefits, which provides comprehensive and ... the leader in defined contribution and ... Benefits’ website, as part of the Affordable Care Act ... will become available through new state health insurance exchanges. ...
(Date:6/19/2013)... York, New York (PRWEB) June 19, 2013 ... pancreatitis and pancreatic cancer continue to mount in courts ... U.S. Food & Drug Administration (FDA) recently held a ... diabetes drugs known as incretin mimetics. According to ... seek additional data from the makers of Januvia and ...
(Date:6/19/2013)... and trauma surgery have had a significant impact ... after major injuries, including burns. Patients who ... are at greatest risk from infections particularly ... or from inflammation-induced multiorgan failure. Now, ... investigators that measures the movement of key immune ...
(Date:6/19/2013)... In a study published in the June 19 online ... team led by researchers from the University of California, ... cellular events that take place when cardiac regeneration occurs ... provide evidence that various cell lines in the heart ... cell types, than previously thought. , More importantly, the ...
Breaking Medicine News(10 mins):Health News:Kleritec Announces Addition of Educational Products. 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 3Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Restoring appropriate movement to immune cells may save seriously burned patients 2Health News:Restoring appropriate movement to immune cells may save seriously burned patients 3Health News:Fate of the heart: Researchers track cellular events leading to cardiac regeneration 2
... first observations following its launch on 1 March 2002 was of ... in Antarctica when 3200 sq km of ice disintegrated within ... triggered by climate warming. ,Now, with ten years of ... an additional loss in Larsen B,s area of 1790 sq km ...
... led by Lauren Cole, a public health graduate student, ... and Director of the Epidemiology Program at LSU Health ... head and neck cancer has risen at sites associated ... increase among middle-aged white men. At the same time, ...
... (April 4, 2012) - Men experience a marked drop in ... a specific type of lung cancer. That,s according to a ... issue of Cancer, the official journal of the ... at the hormone levels in men with anaplastic lymphoma kinase ...
... , WEDNESDAY, April 4 (HealthDay News) -- ... form of progestin-only birth control, best known as Depo-Provera, ... women, new research suggests. For the study, researchers ... 44, who were diagnosed with breast cancer, and more ...
... examine the effects of soy on menopause, researchers have found ... and severity of hot flashes by up to 26 percent, ... Menopause: The Journal of the North American Menopause Association, ... women. Although the effectiveness of soy in alleviating ...
... 4 (HealthDay News) -- Obese white women are less likely ... gender to seek potentially life-saving colon cancer screenings, according to ... obesity is associated with a higher risk for colon cancer ... study leader Dr. Nisa Maruthur, an assistant professor in the ...
Cached Medicine News:Health News:Satellite observes rapid ice shelf disintegration in Antarctic 2Health News:LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men 2Health News:Clinical insight improves treatment with new lung cancer drug 2Health News:Clinical insight improves treatment with new lung cancer drug 3Health News:Depo-Provera Birth Control Might Raise Breast Cancer Risk 2Health News:Soy may alleviate hot flashes in menopause, large-scale study finds 2Health News:Obese White Women Shying Away From Colon Cancer Screening 2
... 15 centrifuge provides all the ... for today's full-service clinical lab ... a speed up to 15,300 ... spin tubes, plates and rotors ...
Sealed Aero-Lok technology centrifuge. AeroLok technology, a brush less permanently lubricated motor, sturdy aluminum cabinet is covered with a durable, baked-on powder coating in an attractive tan c...
... The Rotanta 460 family ... extraordinary line that meets ... demands. They feature high ... Their state-of-the-art technology and ...
... The Rotanta 460 ... an extraordinary line that ... of demands. They feature ... performance. Their state-of-the-art technology ...
Medicine Products: